Laurène Deconinck

Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

Pierre‐Louis Tharaux, Gilles Pialoux, Arthur Pavot et al. · The Lancet Respiratory Medicine · 2021 · 293 citations · Full text

Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial

Aurélien Dinh, Jacques Ropers, Clara Duran et al. · The Lancet · 2021 · 153 citations

Community-acquired Pneumonia, Critical Care Medicine, Antibiotics +7

Germs of thrones - spontaneous decolonization of Carbapenem-Resistant Enterobacteriaceae (CRE) and Vancomycin-Resistant Enterococci (VRE) in Western Europe: is this myth or reality?

Benjamin Davido, Aurore Moussiegt, Aurélien Dinh et al. · Antimicrobial Resistance and Infection Control · 2018 · 43 citations · Full text

Health Sciences, Klebsiella Pneumoniae, Vancomycin-resistant Enterococci +7

Case report study of the first five COVID-19 patients treated with remdesivir in France

Marie Dubert, Benoît Visseaux, Valentina Isernia et al. · International Journal of Infectious Diseases · 2020 · 40 citations · Full text

First Five, Covid-19 Pandemic, Antiviral Therapy +7

Impact of combination therapy and early de-escalation on outcome of ventilator-associated pneumonia caused by <i>Pseudomonas aeruginosa</i>

Laurène Deconinck, Agnès Meybeck, Pierre Patoz et al. · Infectious Diseases · 2017 · 33 citations